Clinical Research Detail Title Of Study A randomized, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week double-blind treatment period assessing the efficacy and safety of lixisenatide in patients with Type 2 diabetes insufficiently controlled with insulin glargine and metformin. Disease Condition In patients with Type 2 diabetes insufficiently controlled with insulin glargine and metformin. Phase of Trial Phase-3 Discipline Diabetology Start date of Trial 12/16/2009 Closing Date of Trial 12/16/2011 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]